Matinas Biopharma Holdings Profit Margin 2012-2019 | MTNB

Current and historical gross margin, operating margin and net profit margin for Matinas Biopharma Holdings (MTNB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Matinas Biopharma Holdings net profit margin as of June 30, 2019 is 0%.
Matinas Biopharma Holdings Annual Profit Margins
Matinas Biopharma Holdings Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.109B $0.000B
Matinas BioPharma is a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its LNC platform technology. The Company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead anti-fungal product candidate, MAT2203, utilizes its proprietary lipid nano-crystal formulation technology for the safe and effective delivery of the broad-spectrum fungicidal agent, amphotericin B. Based on the positive patient clinical data reported in 2017, Matinas is preparing for a potential Phase 2 pivotal trial of MAT2203 for prevention of invasive fungal infections in patients with acute lymphoblastic leukemia.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.114B 35.79
Astellas Pharma (ALPMY) Japan $28.076B 13.77
Takeda Pharmaceutical (TAK) Japan $26.841B 8.38
Eisai (ESALY) Japan $14.517B 24.96
UCB SA (UCBJF) Belgium $14.267B 0.00
Grifols, S.A (GRFS) Spain $14.246B 18.17
Merck (MKGAF) Germany $13.409B 18.30
Ionis Pharmaceuticals (IONS) United States $9.397B 20.27
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.620B 0.00
IPSEN SA ADR (IPSEY) France $8.399B 0.00
Sage Therapeutics (SAGE) United States $8.312B 0.00
Catalent (CTLT) United States $7.586B 30.03
Jazz Pharmaceuticals (JAZZ) Ireland $7.443B 9.80
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.793B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.102B 18.34
FibroGen (FGEN) United States $3.698B 92.50
United Therapeutics (UTHR) United States $3.500B 0.00
Nektar Therapeutics (NKTR) United States $3.495B 0.00
Evotec AG (EVTCY) Germany $3.369B 46.12
Taro Pharmaceutical Industries (TARO) Israel $3.077B 11.03
Tilray (TLRY) Canada $2.985B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.858B 65.52
PTC Therapeutics (PTCT) United States $2.543B 0.00
Portola Pharmaceuticals (PTLA) United States $2.081B 0.00
Xencor (XNCR) United States $2.009B 43.80
Zogenix (ZGNX) United States $1.861B 0.00
Heron Therapeutics (HRTX) United States $1.637B 0.00
USANA Health Sciences (USNA) United States $1.602B 16.07
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.551B 56.44
Corcept Therapeutics (CORT) United States $1.520B 20.89
Ironwood Pharmaceuticals (IRWD) United States $1.510B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.366B 22.53
Theravance Biopharma (TBPH) Cayman Islands $1.341B 0.00
Radius Health (RDUS) United States $1.315B 0.00
Aerie Pharmaceuticals (AERI) United States $1.062B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.044B 4.65
Spectrum Pharmaceuticals (SPPI) United States $1.034B 0.00
ArQule (ARQL) United States $0.950B 0.00
Endo (ENDP) Ireland $0.897B 1.58
TherapeuticsMD (TXMD) United States $0.808B 0.00
Concordia (CXRXF) Canada $0.671B 0.00
Karyopharm Therapeutics (KPTI) United States $0.655B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.631B 0.00
Akebia Therapeutics (AKBA) United States $0.625B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.592B 0.00
Organogenesis Holdings (ORGO) United States $0.583B 0.00
Lannett Co Inc (LCI) United States $0.561B 5.91
Flexion Therapeutics (FLXN) United States $0.538B 0.00
Translate Bio (TBIO) United States $0.531B 0.00
Indivior (INVVY) United States $0.510B 1.84
Dermira (DERM) United States $0.480B 0.00
ImmunoGen (IMGN) United States $0.480B 0.00
Aptorum Group (APM) China $0.478B 0.00
Siga Technologies (SIGA) United States $0.459B 1.07
Dova Pharmaceuticals (DOVA) United States $0.458B 0.00
ChemoCentryx (CCXI) United States $0.443B 0.00
Harpoon Therapeutics (HARP) United States $0.429B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.419B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.416B 18.91
Collegium Pharmaceutical (COLL) United States $0.405B 0.00
Ardelyx (ARDX) United States $0.394B 0.00
Innate Pharma SA (IPHYF) France $0.388B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.365B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.348B 0.00
DURECT (DRRX) United States $0.326B 0.00
CV Sciences (CVSI) United States $0.311B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.298B 0.00
Rafael Holdings (RFL) United States $0.291B 0.00
Xeris Pharmaceuticals (XERS) United States $0.280B 0.00
OptiNose (OPTN) United States $0.278B 0.00
KalVista Pharmaceuticals (KALV) United States $0.278B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.277B 0.00
Recro Pharma (REPH) United States $0.275B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.265B 0.00
Concert Pharmaceuticals (CNCE) United States $0.249B 0.00
CannTrust Holdings (CTST) Canada $0.228B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
Molecular Templates (MTEM) United States $0.211B 0.00
Ocular Therapeutix (OCUL) United States $0.210B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.209B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.194B 0.00
GlycoMimetics (GLYC) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 31.42
Redhill Biopharma (RDHL) Israel $0.168B 0.00
Generex Biotechnology (GNBT) United States $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.159B 0.00
IMV INC (IMV) Canada $0.150B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.146B 0.00
MEI Pharma (MEIP) United States $0.137B 0.00
Cardiome Pharma (CORV) Canada $0.126B 0.00
Jounce Therapeutics (JNCE) United States $0.118B 0.00
Majesco Entertainment (PTE) United States $0.112B 0.00
Mast Therapeutics (SVRA) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ElectroCore (ECOR) United States $0.107B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.103B 0.00
AgeX Therapeutics (AGE) United States $0.099B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Neos Therapeutics (NEOS) United States $0.093B 0.00
Genocea Biosciences (GNCA) United States $0.090B 0.00
Aquestive Therapeutics (AQST) United States $0.090B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
MediWound (MDWD) Israel $0.087B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.087B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.080B 0.00
RENEURON GP (RNUGF) United Kingdom $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 30.24
Natural Alternatives (NAII) United States $0.076B 7.63
Lipocine (LPCN) United States $0.075B 0.00
Novan (NOVN) United States $0.072B 0.00
Champions Oncology (CSBR) United States $0.071B 610.00
Infinity Pharmaceuticals (INFI) United States $0.070B 0.00
Otonomy (OTIC) United States $0.066B 0.00
China SXT Pharmaceuticals (SXTC) China $0.064B 0.00
Jaguar Animal Health (JAGX) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
Capnia (SLNO) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.052B 0.00
CTI BioPharma (CTIC) United States $0.049B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 1.60
Aclaris Therapeutics (ACRS) United States $0.045B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
Melinta Therapeutics (MLNT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Bio-Path Holdings (BPTH) United States $0.033B 0.00
Opexa Therapeutics (ACER) United States $0.032B 0.00
Biomerica (BMRA) United States $0.029B 0.00
IsoRay (ISR) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Onconova Therapeutics (ONTX) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00